The results obtained from the western blotting and immunohistochemistry experiments on clinically collected samples confirmed the up-regulation of RAB26 in the PCa group, with a more pronounced increase observed in high-grade PCa tissues (Fig. 1K). The gene discussed is RAB26; the disease is posterior cortical atrophy.